<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Child Neurology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Child Neurology</journal-title><trans-title-group xml:lang="ru"><trans-title>Русский журнал детской неврологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2073-8803</issn><issn publication-format="electronic">2412-9178</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">226</article-id><article-id pub-id-type="doi">10.17650/2073-8803-2017-12-3-44-50</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">COMPARATIVE ANALYSIS OF THERAPY OUTCOMES IN PATIENTS WITH WEST SYNDROME RECEIVING TETRAСOSACTIDЕ AND OTHER ANTIEPILEPTIC DRUGS</article-title><trans-title-group xml:lang="ru"><trans-title>Сравнительный анализ результатов терапии синдрома Веста тетракозактидом и другими антиэпилептическими препаратами</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Farnosova</surname><given-names>M. E.</given-names></name><name xml:lang="ru"><surname>Фарносова</surname><given-names>М. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Fundamental and Clinical Pharmacology, Institute of Fundamental Medicine and Biology, 18 Kremlevskaya St., Kazan 420000;</p><p>11 Bari Galeeva St., Kazan 420061</p></bio><bio xml:lang="ru"><p>Кафедра фундаментальной и клинической фармакологии Института фундаментальной медицины и биологии, 420000 Казань, ул. Кремлевская, 18;</p><p>420061 Казань, ул. Бари Галеева, 11</p></bio><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gamirova</surname><given-names>R. G.</given-names></name><name xml:lang="ru"><surname>Гамирова</surname><given-names>Р. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Fundamental and Clinical Pharmacology, Institute of Fundamental Medicine and Biology, 18 Kremlevskaya St., Kazan 420000;</p><p>11 Bari Galeeva St., Kazan 420061;</p><p>Department of Pediatric Neurology, 11 Mushtari St., Kazan 420012;</p><p>18 Kremlevskaya St., Kazan 420000</p></bio><bio xml:lang="ru"><p>Кафедра фундаментальной и клинической фармакологии Института фундаментальной медицины и биологии, 420000 Казань, ул. Кремлевская, 18;</p><p> 420061 Казань, ул. Бари Галеева, 11;</p><p/><p>Кафедра детской неврологии, 420012 Казань, ул. Муштари, 11;</p><p>420000 Казань, ул. Кремлевская, 18</p></bio><email>r-gamirov@mail.ru</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/><xref ref-type="aff" rid="aff5"/><xref ref-type="aff" rid="aff6"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan Federal University</institution></aff><aff><institution xml:lang="ru">Казанский федеральный университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Children’s City Hospital No. 8</institution></aff><aff><institution xml:lang="ru">ГАУЗ «Детская городская больница № 8» г. Казани</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Kazan Federal University</institution></aff><aff><institution xml:lang="ru">Казанского федерального университета</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Children’s City Hospital No. 8&#13;
Kazan State Medical Academy, branch of the Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ГАУЗ «Детская городская больница № 8» г. Казани</institution></aff></aff-alternatives><aff-alternatives id="aff5"><aff><institution xml:lang="en">Research Laboratory «Clinical Linguistics», Kazan Federal University</institution></aff><aff><institution xml:lang="ru">ГБОУ ДПО «Казанская государственная медицинская академия» – филиала ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff></aff-alternatives><aff id="aff6"><institution>Научно-исследовательская лаборатория «Клиническая лингвистика» Казанского федерального университета</institution></aff><pub-date date-type="pub" iso-8601-date="2017-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2017</year></pub-date><volume>12</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>44</fpage><lpage>50</lpage><history><date date-type="received" iso-8601-date="2017-12-01"><day>01</day><month>12</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-12-01"><day>01</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, ABV-Press</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, АБВ-пресс</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">ABV-Press</copyright-holder><copyright-holder xml:lang="ru">АБВ-пресс</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://rjdn.abvpress.ru/jour/about/editorialPolicies</ali:license_ref></license></permissions><self-uri xlink:href="https://rjdn.abvpress.ru/jour/article/view/226">https://rjdn.abvpress.ru/jour/article/view/226</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>West syndrome</kwd><kwd>tetracosactide</kwd><kwd>antiepileptic drugs</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром Веста</kwd><kwd>тетракозактид</kwd><kwd>антиэпилептические препараты</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">главный врач ГАУЗ ДГБ № 8 г. Казани Ф. М. Зайкова</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Appleton R.E., Peters A.C., Mumford J.P. et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999;40(11):1627–33. PMID: 10565592.</mixed-citation><mixed-citation xml:lang="ru">Appleton R.E., Peters A.C., Mumford J.P. et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999;40(11):1627–33. PMID: 10565592.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Askalan R., Mackay M., Brian J. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. J Child Neurol 2003;18(3):165–70. DOI: 10.1177/08830738030180030801. PMID: 12731640.</mixed-citation><mixed-citation xml:lang="ru">Askalan R., Mackay M., Brian J. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. J Child Neurol 2003;18(3):165–70. DOI: 10.1177/08830738030180030801. PMID: 12731640.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Bobele G.B., Ward K.E., Bodensteiner J.B. Hypertrophic cardiomyopathy during corticotropin therapy for infantile spasm. A clinical and echocardiographic study. Am J Dis Child 1993;147(2):223–5. DOI: 10.1001/archpedi.1993.021602601133037. PMID: 8381257.</mixed-citation><mixed-citation xml:lang="ru">Bobele G.B., Ward K.E., Bodensteiner J.B. Hypertrophic cardiomyopathy during corticotropin therapy for infantile spasm. A clinical and echocardiographic study. Am J Dis Child 1993;147(2):223–5. DOI: 10.1001/archpedi.1993.021602601133037. PMID: 8381257.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Cilio M.R., Kartashov A.I., Vigevano F. The long-term use of felbamate in children with severe refractory epilepsy. Epilepsy Res 2001;47:1–7. DOI: 10.1016/S0920-1211(01)00290-X. PMID: 11673015.</mixed-citation><mixed-citation xml:lang="ru">Cilio M.R., Kartashov A.I., Vigevano F. The long-term use of felbamate in children with severe refractory epilepsy. Epilepsy Res 2001;47:1–7. DOI: 10.1016/S0920-1211(01)00290-X. PMID: 11673015.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Hancock E.C., Osborne J.P., Edwards S.W. Treatment of infantile spasms. Cochrane Database Syst Rev 2013;5(6):CD001770. DOI: 1002/14651858.CD001770.pub3. PMID: 23740534.</mixed-citation><mixed-citation xml:lang="ru">Hancock E.C., Osborne J.P., Edwards S.W. Treatment of infantile spasms. Cochrane Database Syst Rev 2013;5(6):CD001770. DOI: 1002/14651858.CD001770.pub3. PMID: 23740534.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Hrachovy R.A., Frost J.D. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 2003;20(6):408–25. PMID: 14734931.</mixed-citation><mixed-citation xml:lang="ru">Hrachovy R.A., Frost J.D. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J Clin Neurophysiol 2003;20(6):408–25. PMID: 14734931.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Lawlor K.M., Devlin A.M. Levetiracetam in the treatment of infantile spasms. Eur J Paediatr Neurol 2005;9:e19–22. DOI: 10.1016/j.ejpn.2004.11.001. PMID: 15701562.</mixed-citation><mixed-citation xml:lang="ru">Lawlor K.M., Devlin A.M. Levetiracetam in the treatment of infantile spasms. Eur J Paediatr Neurol 2005;9:e19–22. DOI: 10.1016/j.ejpn.2004.11.001. PMID: 15701562.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Lombroso C.T. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia 1983;24:135–58. DOI: 10.1111/j.1528-1157.1983. tb04874.x. PMID: 6299719.</mixed-citation><mixed-citation xml:lang="ru">Lombroso C.T. A prospective study of infantile spasms: clinical and therapeutic correlations. Epilepsia 1983;24:135–58. DOI: 10.1111/j.1528-1157.1983. tb04874.x. PMID: 6299719.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Mackay M.T., Weiss S.K., Adams-Webber T. et al. Practice parameter: medical treatment of infantile spasms. Report of the Аmerican Academy of Neurology and the Child Neurology Society. Neurology 2004;62(10):1668–81. PMID: 15159460.</mixed-citation><mixed-citation xml:lang="ru">Mackay M.T., Weiss S.K., Adams-Webber T. et al. Practice parameter: medical treatment of infantile spasms. Report of the Аmerican Academy of Neurology and the Child Neurology Society. Neurology 2004;62(10):1668–81. PMID: 15159460.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Mikati M.A., Fayad M., Koleilat M. et al. Efficacy, tolerability, and kinetics of lamotrigine in infants. J Pediatr 2002;141:31–5. DOI: 10.1067/ mpd.2002.125256. PMID: 12091848.</mixed-citation><mixed-citation xml:lang="ru">Mikati M.A., Fayad M., Koleilat M. et al. Efficacy, tolerability, and kinetics of lamotrigine in infants. J Pediatr 2002;141:31–5. DOI: 10.1067/ mpd.2002.125256. PMID: 12091848.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Pellock J.M., Hrachovy R., Shinnar S. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51(10):2175–89. DOI: 10.1111/j.1528-1167.2010.02657.x. PMID: 20608959.</mixed-citation><mixed-citation xml:lang="ru">Pellock J.M., Hrachovy R., Shinnar S. Infantile spasms: a U.S. consensus report. Epilepsia 2010;51(10):2175–89. DOI: 10.1111/j.1528-1167.2010.02657.x. PMID: 20608959.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Peltzer B., Alonso W.D., Porter B.E. Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol 2009;24(4):400–5. DOI: 10.1177/0883073808324538. PMID: 19225138.</mixed-citation><mixed-citation xml:lang="ru">Peltzer B., Alonso W.D., Porter B.E. Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol 2009;24(4):400–5. DOI: 10.1177/0883073808324538. PMID: 19225138.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Rajaraman R.R., Lay J., Alayari A. et al. Prevention of infantile spasms relapse: Zonisamide and topiramate provide no benefit. Epilepsia 2016;57(8):1280–7. DOI: 10.1111/epi.13442. PMID: 27312124.</mixed-citation><mixed-citation xml:lang="ru">Rajaraman R.R., Lay J., Alayari A. et al. Prevention of infantile spasms relapse: Zonisamide and topiramate provide no benefit. Epilepsia 2016;57(8):1280–7. DOI: 10.1111/epi.13442. PMID: 27312124.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Riikonen R. Recent Advances in the Pharmacotherapy of Infantile Spasms. CNS Drugs 2014;28:279–90. DOI: 10.1007/ s40263-014-0139-5. PMID: 24504827.</mixed-citation><mixed-citation xml:lang="ru">Riikonen R. Recent Advances in the Pharmacotherapy of Infantile Spasms. CNS Drugs 2014;28:279–90. DOI: 10.1007/ s40263-014-0139-5. PMID: 24504827.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Riikonen R., Simell O., Jaaskelainen J. et al. Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms. Arch Dis Child 1986;61:671–6. DOI: 10.1136/ adc.61.7.671. PMID: 3017235.</mixed-citation><mixed-citation xml:lang="ru">Riikonen R., Simell O., Jaaskelainen J. et al. Disturbed calcium and phosphate homeostasis during treatment with ACTH of infantile spasms. Arch Dis Child 1986;61:671–6. DOI: 10.1136/ adc.61.7.671. PMID: 3017235.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16. Shamir R., Garty B.Z. Pneumocystis carinii pneumonia associated with adrenocorticotrophic hormone treatment for infantile spasms. Eur J Pediatr 1992;151(11):867. DOI: 10.1007/ BF01957945. PMID: 1468469.</mixed-citation><mixed-citation xml:lang="ru">Shamir R., Garty B.Z. Pneumocystis carinii pneumonia associated with adrenocorticotrophic hormone treatment for infantile spasms. Eur J Pediatr 1992;151(11):867. DOI: 10.1007/ BF01957945. PMID: 1468469.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17. Sorel L., Dusaucy-Bayloye H. A propos de 21 cas d‘hypsarythmie de Gibbs. Son Traitement spectaculaire par l’ACTH. Acta Neurol Psychiatr Belg 1958;58(2):130–41. PMID: 13532578.</mixed-citation><mixed-citation xml:lang="ru">Sorel L., Dusaucy-Bayloye H. A propos de 21 cas d‘hypsarythmie de Gibbs. Son Traitement spectaculaire par l’ACTH. Acta Neurol Psychiatr Belg 1958;58(2):130–41. PMID: 13532578.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18. Veggiotti P., Cieuta C., Rex E., Dulac O. Lamotrigine in infantile spasms. Lancet 1994;344:1375–6. DOI: 10.1016/S0140-6736(94)90741-2. PMID: 7968065.</mixed-citation><mixed-citation xml:lang="ru">Veggiotti P., Cieuta C., Rex E., Dulac O. Lamotrigine in infantile spasms. Lancet 1994;344:1375–6. DOI: 10.1016/S0140-6736(94)90741-2. PMID: 7968065.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19. Weber A., Cole J.W., Mytinger J.R. Infantile spasms respond poorly to topiramate. Pediatr Neurol 2015;53(2):130–4. DOI: 10.1016/j.pediatrneurol.2015.05.003.</mixed-citation><mixed-citation xml:lang="ru">Weber A., Cole J.W., Mytinger J.R. Infantile spasms respond poorly to topiramate. Pediatr Neurol 2015;53(2):130–4. DOI: 10.1016/j.pediatrneurol.2015.05.003.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20. Wheless J.W., Gibson P.A., Rosbeck K.L. Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatr 2012;12:108. DOI: 10.1186/1471-2431-12-108. PMID: 22830456.</mixed-citation><mixed-citation xml:lang="ru">Wheless J.W., Gibson P.A., Rosbeck K.L. Infantile spasms (West syndrome): update and resources for pediatricians and providers to share with parents. BMC Pediatr 2012;12:108. DOI: 10.1186/1471-2431-12-108. PMID: 22830456.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21. Wild J.M., Chiron C., Ahn H. et al. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS Drugs 2009;23(11):965– 82. DOI: 10.2165/11317650-000000000-00000. PMID: 19845417.</mixed-citation><mixed-citation xml:lang="ru">Wild J.M., Chiron C., Ahn H. et al. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS Drugs 2009;23(11):965– 82. DOI: 10.2165/11317650-000000000-00000. PMID: 19845417.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22. Wilmshurst J.M., Gaillard W.D., Vinayan K.P. et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia 2015;56(8):e1185–97. DOI: 10.1111/epi.13057. PMID: 26122601.</mixed-citation><mixed-citation xml:lang="ru">Wilmshurst J.M., Gaillard W.D., Vinayan K.P. et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia 2015;56(8):e1185–97. DOI: 10.1111/epi.13057. PMID: 26122601.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23. Yanai S., Hanai T., Narazaki O. Treatment of infantile spasms with zonisamide. Brain Dev 1999;21:157–61. DOI: 10.1016/s0387-7604(98)00080-1. PMID: 10372900.</mixed-citation><mixed-citation xml:lang="ru">Yanai S., Hanai T., Narazaki O. Treatment of infantile spasms with zonisamide. Brain Dev 1999;21:157–61. DOI: 10.1016/s0387-7604(98)00080-1. PMID: 10372900.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24. Young R.S., Fripp R.R., Stern D.R., Darowish C. Cardiac hypertrophy associated with ACTH therapy for childhood seizure disorder. J Child Neurol 1987;2(4):311–2. DOI: 10.1177/088307388700200417. PMID: 2821097.</mixed-citation><mixed-citation xml:lang="ru">Young R.S., Fripp R.R., Stern D.R., Darowish C. Cardiac hypertrophy associated with ACTH therapy for childhood seizure disorder. J Child Neurol 1987;2(4):311–2. DOI: 10.1177/088307388700200417. PMID: 2821097.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
